GB Patent

GB8531071D0 — Therapeutic compound

Assigned to Boots Co PLC · Expires 1986-01-29 · 40y expired

What this patent protects

N,N-Dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate is a non-hygroscopic material which can be used as a pharmaceutical in the treatment of depression.

USPTO Abstract

N,N-Dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate is a non-hygroscopic material which can be used as a pharmaceutical in the treatment of depression.

Drugs covered by this patent

Patent Metadata

Patent number
GB8531071D0
Jurisdiction
GB
Classification
—
Expires
1986-01-29
Drug substance claim
No
Drug product claim
No
Assignee
Boots Co PLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.